Search by Drug Name or NDC

    NDC 00363-0770-01 HEADACHE RELIEF 250; 250; 65 mg/1; mg/1; mg/1 Details

    HEADACHE RELIEF 250; 250; 65 mg/1; mg/1; mg/1

    HEADACHE RELIEF is a ORAL TABLET, COATED in the HUMAN OTC DRUG category. It is labeled and distributed by WALGREENS. The primary component is ACETAMINOPHEN; ASPIRIN; CAFFEINE.

    Product Information

    NDC 00363-0770
    Product ID 0363-0770_e3acc0ae-b992-671b-e053-2995a90a2d07
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name HEADACHE RELIEF
    Proprietary Name Suffix n/a
    Non-Proprietary Name ACETAMINOPHEN, ASPIRIN, CAFFEINE
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET, COATED
    Route ORAL
    Active Ingredient Strength 250; 250; 65
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; ASPIRIN; CAFFEINE
    Labeler Name WALGREENS
    Pharmaceutical Class Anti-Inflammatory Agents, Non-Steroidal [CS], Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Cyclooxygenase Inhibitors [MoA], Decreased Platelet Aggregation [PE], Decreased Prostaglandin Production [PE], Methylxanthine [E
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part343
    Listing Certified Through 2024-12-31

    Package

    NDC 00363-0770-01 (00363077001)

    NDC Package Code 0363-0770-01
    Billing NDC 00363077001
    Package 1 BOTTLE in 1 CARTON (0363-0770-01) / 100 TABLET, COATED in 1 BOTTLE
    Marketing Start Date 2021-03-31
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL b5a45daa-05b1-4d6d-e053-2995a90a8444 Details

    Revised: 7/2022